CIK 0001818382
- Non-accelerated filer
- Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851763759
- Phone
- +1 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President, CEO and Director sold 630,148 shares at an average $7.17 ($4,520,024)
- 4 Open-market sale Director sold 630,148 shares at an average $7.17 ($4,520,024)
- 4 Open-market buy President, CEO and Director bought 2,362 shares at $6.35 ($14,999)
- 4 Open-market buy Director bought 2,362 shares at $6.35 ($14,999)
- 4 Open-market sale President, CEO and Director sold 1,001,852 shares at an average $7.82 ($7,832,200)
- 4 Open-market sale Director sold 1,001,852 shares at an average $7.82 ($7,832,200)
- 4 Open-market buy President, CEO and Director bought 2,050 shares at $7.37 ($15,109)
- 4 Open-market buy Director bought 2,050 shares at $7.37 ($15,109)
- 4 Open-market sale Chief Operating Officer sold 191,511 shares at an average $8.15 ($1,561,605)
- 4 Open-market buy Director bought 8,005 shares at an average $6.25 ($50,030)
- 4 Exercise or conversion Director acquired 600 shares (option exercise)
- 4 Exercise or conversion Director acquired 600 shares (option exercise)
- 4 Open-market buy Director bought 100,000 shares at an average $6.68 ($667,500)
Page 5 of 12 · 235 filings